Abstract
My interests lie in the basic cellular events which control the progression of a cell through a division cycle, the events which get cells from G 0 into G 1, G 1 into S, S into G 2 and G 2 into M (Fig. 1). For some years we have been concentrating on the last of these, the study of the essential requirements of a post S-phase cell which allow it to enter mitosis, i.e. we are concerned with the significance of the G 2 interval in mammalian cells. Any treatment, physical or chemical, which alters the progression of cells through G 2 and mitosis is potentially of interest in helping to analyse the rate-limiting (control) mechanisms. Adriamycin (Ad) and daunomycin (Da) come into this category.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Silvestrini, R., Gambarucci, C., Dasdia, T.: Tumori 56, 137–148 (1970).
Rusconi, A., Di Marco, A.: Cancer Res. 29, 1507–1511 (1969).
Silvestrini, R., Di Marco, A., Dasdia, T.: Cancer Res. 30, 966–973 (1970).
Terasima, T., Yasukawa, M., Umezawa, H.: Gann 61, 513–516 (1970).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Springer-Verlag, Berlin Heidelberg
About this paper
Cite this paper
Wheatley, D.N. (1972). Action of Adriamycin on HeLa Cells. Evidence of a G2 Inhibition. In: Carter, S.K., Marco, A.D., Ghione, M., Krakoff, I.H., Mathé, G. (eds) International Symposium on Adriamycin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-95227-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-95227-2_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-95229-6
Online ISBN: 978-3-642-95227-2
eBook Packages: Springer Book Archive